Chronic HBV infection remains one of the most common causes of chronic liver disease. Emmet Keeffe, MD, MACP, talks about ongoing issues in management, as framed by data presented at AASLD 2007. Medscape Gastroenterology
Simvastatin is effective in lowering portal pressure and improving liver perfusion in patients with cirrhosis, according to findings published in the May issue of Gastroenterology. Reuters Health Information
Hepatocellular carcinoma patients who underwent radio frequency ablation (RFA) had a similar survival rate to those who had a surgical resection in a new study from China. Reuters Health Information
A study shows that the Model for End-Stage Liver Disease and the serum sodium concentration are important predictors of survival among candidates for liver transplantation. Medscape Medical News
